| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 88831 |
3,6-d二肼基-1,2,4,5-四嗪(DHT) |
156 |
WYQ |
2024-12-03 |
| 88832 |
DOTA-D-phe1-Tyr3-奥曲肽 ,Ga-68-DOTA-TATE |
134 |
wyh |
2024-12-03 |
| 88833 |
DOTA-cCCK,DOTA偶联胆囊收缩素(CCK)受体 |
239 |
wyh |
2024-12-03 |
| 88834 |
3,6-d氨基-1,2,4,5-四嗪(DATZ) |
165 |
WYQ |
2024-12-03 |
| 88835 |
3-d氨基-6-(3,5-二甲基乙基吡唑-1-基)-1,2,4,5-四嗪(ADMPT) |
196 |
WYQ |
2024-12-03 |
| 88836 |
[DOTA]LTT-SS28 ,生长抑素模拟物 |
198 |
wyh |
2024-12-03 |
| 88837 |
DOTA-minigastrin (CP04) , DOTA-小胃泌素(CP04) |
220 |
wyh |
2024-12-03 |
| 88838 |
DOTA-rhuEpo ; DOTA-酰肼偶联rhuEpo |
128 |
wyh |
2024-12-03 |
| 88839 |
1,2,4,5-四嗪 , 化学式:C2H2N4 |
249 |
WYQ |
2024-12-03 |
| 88840 |
DOTA-Benerotide ;靶向生长抑素受体 |
122 |
wyh |
2024-12-03 |
| 88841 |
1,2,4,5-Tetrazines by Palladium Catalysis(钯催化1,2,4,5-四嗪的合成) |
132 |
WYQ |
2024-12-03 |
| 88842 |
5-苯基-1,2,4-三嗪-3-胺为例,为C9H8N4 |
142 |
WYQ |
2024-12-03 |
| 88843 |
DOTA-PEG-LA-AuNP,DOTA-PEG-硫辛酸修饰纳米金纳米粒子 |
177 |
wyh |
2024-12-03 |
| 88844 |
3,6-二(吡啶-2-基)-1,2,4,5-四嗪(pytz) |
199 |
WYQ |
2024-12-03 |
| 88845 |
HYNIC-PEG11-Tz;联肼尼克酰胺-十一聚乙二醇-四嗪;HYNIC-PEG11-Tetrazine |
189 |
WYQ |
2024-12-03 |
| 88846 |
DOTA-NT肽偶联金纳米粒子 ,DOTA-NT-AuNPs |
140 |
wyh |
2024-12-03 |
| 88847 |
[Zr-89]Zr-DFO-PEG5-Tz;[Zr-89]Zr-DFO-PEG5-Tetrazine |
184 |
WYQ |
2024-12-03 |
| 88848 |
MeTz-NOTA-RGD;甲基四嗪-大环配体-多肽 |
189 |
WYQ |
2024-12-03 |
| 88849 |
DOTA-Tyr(3)-奥曲肽, DOTA-Tyr(3)-Octreotide |
132 |
wyh |
2024-12-03 |
| 88850 |
AgNPs–pytz(3,6-二(吡啶-2-基)-1,2,4,5-四嗪包覆的银纳米粒子) |
146 |
WYQ |
2024-12-03 |
| 88851 |
3,6-di(pyridin-2-yl)-1,2,4,5-s-tetrazine (pytz,3,6-二(吡啶-2-基)-1,4-二氢-1,2,4,5-四嗪) |
163 |
WYQ |
2024-12-03 |
| 88852 |
DOTA-叶酸偶联物,DOTA-Folate |
171 |
wyh |
2024-12-03 |
| 88853 |
CQDs-DOTA-Yb,镱-DOTA螯合物功能化碳量子点 |
149 |
wyh |
2024-12-03 |
| 88854 |
3,6-dihydrazino-s-tetrazine (DHT,3,6-二肼基-s-四嗪) |
160 |
WYQ |
2024-12-03 |
| 88855 |
BCN-PEG-PAMAM ,环丙烷环辛炔-聚乙二醇-聚酰胺 |
183 |
zyl |
2024-12-03 |
| 88856 |
(DNAZTzDMP)2Ni(H2O)2][NO3]2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
145 |
WYQ |
2024-12-03 |
| 88857 |
AB1-HLys-DOTA,DOTA偶联阳离子肽 |
140 |
wyh |
2024-12-03 |
| 88858 |
PAMAM-PEG-CKAAKN 树枝状大分子聚酰胺胺-聚乙二醇-CKAAKN多肽 |
150 |
zyl |
2024-12-03 |
| 88859 |
(NH2TzDMP)3Ni][NO3]2;3-氨基-6-(3,5-二甲基吡唑)四嗪配合物 |
121 |
WYQ |
2024-12-03 |
| 88860 |
(DNAZTzDMP)2Co(H2O)2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
160 |
WYQ |
2024-12-03 |
| 88861 |
DOTA-1-nal 3-奥曲肽,Ga-DOTA-1-Nal3-octreotide |
111 |
wyh |
2024-12-03 |
| 88862 |
PAMAM-PEG-SP94 树枝状大分子聚酰胺胺-聚乙二醇-SP94多肽 |
140 |
zyl |
2024-12-03 |
| 88863 |
[(DNAZTzDMP)2Co(H2O)2](3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物) |
165 |
WYQ |
2024-12-03 |
| 88864 |
LLP2A-DOTA-PEG(2000), LLP2A-DOTA-聚乙二醇(2000) |
133 |
wyh |
2024-12-03 |
| 88865 |
[(NH2TzDMP)2Co(H2O)(NO3)][NO3](3-氨基-6-(3,5-二甲基吡唑)四嗪配合物) |
213 |
WYQ |
2024-12-03 |
| 88866 |
3-(3,3'-dinitroazetidine)-6-(3,5-dimethylpyrazole)tetrazine(DNAZTzDMP) |
144 |
WYQ |
2024-12-03 |
| 88867 |
PAMAM-PEG-PTP 树枝状大分子聚酰胺胺-聚乙二醇-PTP多肽 |
139 |
zyl |
2024-12-03 |
| 88868 |
DOTA-SSTR;DOTA修饰生长抑素受体SSTR |
200 |
wyh |
2024-12-03 |
| 88869 |
NOTA-PEG(7)-Tz;大环化合物-七聚乙二醇-四嗪;NOTA-PEG(7)-Tetrazine |
155 |
WYQ |
2024-12-03 |
| 88870 |
PAMAM-PEG-RGDS 树枝状大分子聚酰胺胺-聚乙二醇-RGDS多肽 |
147 |
zyl |
2024-12-03 |
| 88871 |
PEGylated tetrazine;PEG4-Tz;聚乙二醇化四嗪;PEGylated Tz |
182 |
WYQ |
2024-12-03 |
| 88872 |
DOTA-ZOL, DOTA-唑来膦酸 |
126 |
wyh |
2024-12-03 |
| 88873 |
NHS-s-s-tetrazine;N-羟基琥珀酰亚胺-双硫键-四嗪;NHS-s-s-Tz |
167 |
WYQ |
2024-12-03 |
| 88874 |
PAMAM-PEG-c(RGDfC) ,树枝状大分子聚酰胺胺-聚乙二醇-c(RGDfC)多肽 |
188 |
zyl |
2024-12-03 |
| 88875 |
3-amino-6-(3,5-dimethylpyrazole)tetrazine(NH2TzDMP、3-氨基-6-(3,5-二甲基吡唑)四嗪) |
105 |
WYQ |
2024-12-03 |